Clinical Trials Directory

Trials / Completed

CompletedNCT04956562

Effect of Sinovac on Survival in Intensive Care Unit

Effect of Inactivated COVID-19 Vaccine, Sinovac on Survival in Intensive Care Unit

Status
Completed
Phase
Study type
Observational
Enrollment
96 (actual)
Sponsor
Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
Sex
All
Age
65 Years
Healthy volunteers

Summary

Effect of Inactivated COVID-19 Vaccine (Sinovac) on survival in intensive care unit, Single Center Experience

Detailed description

Turkey has started vaccinate healthcare professionals at 13 January 2021 by Sinovac vaccine and declared a step by step inclusion schedule The primary aim of the study is to compare clinical, laboratory and survival data of COVID-19 patients who were vaccinated at least 14 days before enrollment to the study with COVID-19 patients not vaccinated although they would have. The secondary aim is to compare age of enrolled patients to ICU due to SARS-CoV-2 infection with patients admitted to ICU before start of vaccination program.

Conditions

Timeline

Start date
2021-04-01
Primary completion
2021-05-15
Completion
2021-05-15
First posted
2021-07-09
Last updated
2021-07-09

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT04956562. Inclusion in this directory is not an endorsement.

Effect of Sinovac on Survival in Intensive Care Unit (NCT04956562) · Clinical Trials Directory